Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedRemoved 'Multiple myeloma' and 'MedlinePlus Genetics' from the Related Topics section. The change does not affect core study content or enrollment criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedLocations section updated to include Canada (Alberta, British Columbia, Ontario) and Rome; removed U.S. state locations (Alabama, Georgia, Massachusetts, New York, South Carolina, Washington). Revision label updated to v3.3.3.SummaryDifference0.8%

- Check21 days agoChange Detected- Removed 'Multiple myeloma' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedAdded related topic tag: Multiple myeloma and a MedlinePlus Genetics link. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check50 days agoChange DetectedAncillary items such as the government funding notice and related topics (e.g., MedlinePlus Genetics) were removed from the page, and this does not affect the study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and added 'MedlinePlus Genetics' as a related topic on the study page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.